Abu Dhabi's ADIA Backs Indian MedTech Firm Meril with $200M.

Meril Life Sciences, a global leader in medical technology, has secured a significant investment of $200 million from a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA). This strategic infusion of capital values the Indian medical devices firm at an impressive $6.6 billion.

The investment will give ADIA a 3 percent stake in Meril Life Sciences. This move brings together two major global investors, with ADIA joining Warburg Pincus in backing the company.Founded by the Bilakhia Group, Meril Life Sciences has established itself as a frontrunner in MedTech innovation. The company is renowned for its focus on developing clinically advanced solutions across a diverse range of medical specialties, including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics, and Surgical Robotics. This investment is poised to further accelerate Meril's research, development, and global expansion initiatives.